Aidoo Group of Companies
is made up of the following:
*Company format: Private
Dr. Frank Aidoo, PhD., Chief Scientist and Pioneer,
Founder and Chairman.
Organizational and Structural Makeup
Aidoo Enzyme and Alkaloid Research
is the entity within the Aidoo Group that manages and maintains
all the copyrights, trademarks, intellectual property rights;
patent rights—royalties and goodwill of all of Dr. Aidoo’s
It oversees and protects his interest—including trade
secrets; and all his discoveries within the enzyme and alkaloid
platforms. (Dr. Aidoo is the discoverer of 35 Newly-Formatted
Enzymes; and 12 Virgin Alkaloids of importance within the pharmaceutical
and medicinal fields).
Aidoo Enzyme and Alkaloid Research is the keeper
of the intellectual principles and tools; including the newly
empirical attributions—the style(s) and gEnecidal fundamentals
and composites on which the newly-recorded research are mounted—be
in the arena of Alopecia, Cancer and Diabetes; including other
idiopathic “effeduals.” *All the newly—diametrical
concepts and evaluates—including formularies are held
under this division.
wing of Aidoo Group
manufactures all of Aidoo Group’s brands; and Peter Guerriero
is the Chief Operation Office.
International Research and Marketing is the Exclusive
Marketing entity within the Aidoo Group; and it handles all
International distributorship appointments; including pharmacies
and supermarkets across the world: Dennis Pierce is the Vice-President.
is the North America’s marketing wing of Aidoo Group;
and it has been organized to distribute the AidooAid Breakthrough
Products in United States and Canada: Dr. Aidoo has appointed
Hank Meyer as the Chief Marketing Officer.
will offer opportunities to qualified firms, doctors and professionals
within the wellness industry to handle the AidooAid products.
Affiliate programs to help individuals wishing to benefit from
Dr. Aidoo’s work will also be created—including
retail distributorships and Direct Marketing opportunities—all
within the United States and Canada.
International (Trinidad and Tobago) Ltd., Caribbean
and South America Markets
International (T/T) Ltd is the Aidoo Group's wing organized
to handle the Caribbean and South American markets; and its
headed by Mr. Ken Hunte, Vice President and General Director.
International (Ghana) Ltd., Sub-Saharan African Markets
International (Ghana) Ltd: As a hub to the Sub-Saharan
African markets, Ghana, a progressively-viable country in West
Africa has been chosen, organized and established to distribute
the AidooAid Breakthroughs of Products in the region. Mr. Enoch
Baah heads the operation as Regional Director.
Aidoo's Human Consensus and Inter Mutual Harmony Panel.
Human Consensus and Inter Mutual Harmony Panel: This
is an organized group—by invitation only which Dr. Aidoo
has established and brought together 12 physicians and scientists
in different disciplines to explore and utilize some of his
discoveries within the realm of enzyme and alkaloid platforms:
It's made up of prominent individuals in science and medicine
from major institutions and settings. A close group, it is lead
by Professor Aidoo; and it’s expected—just as the
breakthroughs for the Alopecia/Baldness and Hair Loss Programs,
that, breakthroughs in cancer and diabetes will be announced
in the near future…including some idiopathic diseases—all
instrumented on the style and expertise established by the professor.
***Again, all Children across the world will be treated for
free under the AidooAid Children Foundation.
AidooAid Free Treatment for Children with Alopecia
is a Foundation organized by Dr. Aidoo to help children suffering
from Alopecia across the world for free. Doctors from all nations
are being recruited to diagnose these children and sign them
under the program. The Website is AidooAid.org. Dr. Aidoo has
appointed Dr. Angel DeMola, MD., as the Chief Medical and Clinical
Director of the Foundation; Dr. DeMola will lead all our medical
doctors under the program.
...No man on his own could have achieved this BREAKTHROUGH!
...ITS MERIT IS OF A HIGHER POWER! --For, what the ENTIRE MULTI-BILLION-DOLLAR
PHARMACEUTICAL INDUSTRY COULD NOT ACHIEVE, WE HAVE ACHIEVED!